DIGITAL THERAPEUTICS STARTUP RESPIREE™ GAINS US FDA CLEARANCE FOR ITS RS001 CARDIO-RESPIRATORY WEARABLE

SINGAPORE, March 8, 2023 /PRNewswire/ — Digital therapeutics startup Respiree has received the United States Food and Drug Administration’s 510(k) clearance for its RS001 cardio-respiratory wearable. The RS001 is a chest wearable that measures respiration directly and can be used on…

Leave a Reply

Your email address will not be published. Required fields are marked *